Independent Advisor Alliance Makes New $577,000 Investment in Phibro Animal Health Corporation $PAHC

Key Points

• Independent Advisor Alliance has acquired a new stake in Phibro Animal Health Corporation, purchasing 26,995 shares valued at approximately $577,000 during the first quarter of the year.
• Several hedge funds have recently bought shares of Phibro Animal Health, increasing institutional ownership to 99.34% of the company’s stock.
• Equities analysts have set various price targets for Phibro Animal Health, with the consensus price target currently at $24.40 and a mix of ratings ranging from sell to buy.

Independent Advisor Alliance bought a new position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 26,995 shares of the company's stock, valued at approximately $577,000. Independent Advisor Alliance owned 0.07% of Phibro Animal Health at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of PAHC. Point72 Asia Singapore Pte. Ltd. purchased a new position in Phibro Animal Health during the fourth quarter worth about $29,000. National Bank of Canada FI purchased a new position in Phibro Animal Health during the first quarter worth about $30,000. Lazard Asset Management LLC raised its stake in Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after purchasing an additional 1,589 shares during the period. Aquatic Capital Management LLC acquired a new stake in shares of Phibro Animal Health during the fourth quarter valued at about $69,000. Finally, Virtus Fund Advisers LLC acquired a new stake in shares of Phibro Animal Health during the fourth quarter valued at about $69,000. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Up 0.9%

Shares of PAHC stock traded up $0.28 during trading on Tuesday, reaching $31.53. The company's stock had a trading volume of 28,869 shares, compared to its average volume of 258,661. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of 40.40, a P/E/G ratio of 0.51 and a beta of 0.80. The stock's 50-day moving average price is $27.71 and its 200 day moving average price is $23.87. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $31.80.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Shareholders of record on Wednesday, September 3rd will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.5%. The ex-dividend date is Wednesday, September 3rd. Phibro Animal Health's payout ratio is 61.54%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Morgan Stanley set a $26.00 price target on shares of Phibro Animal Health and gave the company an "equal weight" rating in a research report on Wednesday, June 25th. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and lifted their price target for the company from $25.00 to $35.00 in a research report on Monday, July 7th. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target for the company in a research report on Monday, June 16th. Finally, BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. One investment analyst has rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Reduce" and an average price target of $24.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.